Decision Nº O/239/15 from Intellectual Property Office - (Patent decisions), 26 May 2015
| Judge | Mr P Slater |
| Court | Intellectual Property Office (United Kingdom) |
| Patent Number | GB1402346.9 |
| Date | 26 May 2015 |
| Administrative Decision Number | O/239/15 |
| Parties | Trakcel Ltd |
BL O/239/15
26 May 2015.
APPLICANT
Trakcel Ltd
ISSUE
Whether patent application number GB1402346.9
complies with section 1(2)
HEARING OFFICER
Peter Slater
DECISION
1 Patent application GB1402346.9 entitled “Tracking of physiological or medicinal
samples” is derived from the corresponding PCT application filed on the 7 February
2013 and published as WO2013/117928. The application claims an earliest priority
date of 10 February 2012, and was republished on 16 April 2014 with the serial
number GB2507019.
2 Following several rounds of examination and amendment, the examiner remained of
the view that the claimed invention was excluded from patentability under section
1(2). With the situation unresolved the applicant asked to be heard and the matter
came before me at a hearing on the 23 March 2015. The applicant was represented
by Dr Cerian Jones of Urquhart-Dykes & Lord LLP. The examiner Stephen
Richardson was also present, as was hearing assistant Joseph Mitchell and
observer Solomon Williams-Wadley.
3 The examiner also raised objections in relation to excluded matter under Section 4A,
inventive step, support and clarity and has noted that a search for independent claim
11 has yet to be performed. However, these matters have been deferred pending the
outcome of the hearing.
The invention
4 The invention relates to a method of tracking physiological or medicinal samples
through a sequence of processing operations.
5 There are four main steps to the method. The medicinal or physiological sample (for
example physiological material harvested or collected from a patient by medical
personnel) is provided. The sample then passes through one or more logistic steps,
through one or more processing steps and finally, the sample is administered to a
patient in an administration step.
To continue reading
Request your trial